My Care My Voice: helping patients and clinicians start palliative care conversations
Official title: Implementation and Evaluation of "My Care My Voice": a Program Aimed at Facilitating Conversations About Topics Such as Palliative Care
Run by University Hospital, Ghent · NCT07402057 · Data updated 2026-11-12
This program tries to help oncologists, hospital staff, and adults with advanced cancer start timely palliative care conversations using brief materials and simple workflow changes in three Belgian hospitals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 271 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Drugs / interventions | radiation |
| Locations | 4 sites (Aalst, East-Flanders and 3 other locations) |
| Status | Recruiting |
| Started | March 17, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07402057 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) with advanced, non-curable cancer treated at one of the participating hospitals, plus oncologists and hospital staff who regularly care for them.
✕Probably not a fit
Patients with curable disease, those already receiving specialized palliative or hospice care, or those treated outside the participating hospitals are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
My Care My Voice implements videos, leaflets, and workflow supports to prompt palliative care conversations between clinicians and adults with advanced cancer. The project is interventional and multi-center, with a preparatory feasibility phase plus combined effect and process evaluations to measure changes in clinician intention and behavior and the quality of implementation. Participants include oncologists, other clinicians, implementer staff, and adult patients with non-curable cancer at three hospitals in East Flanders, Belgium. Data collection uses surveys, interviews, and observations to assess acceptability, feasibility, and how the materials can be integrated into routine care.
Why it matters
Potential benefit: If successful, the program could lead to earlier palliative care conversations and better symptom control and quality of life for patients with advanced cancer.
How similar studies have gone: Previous trials of early palliative care have shown improvements in symptom control and quality of life, but implementation programs like My Care My Voice are less studied and partly novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (physician): * Oncologist (medical oncologist, radiation oncologist, etc.), radiologist, organ specialist, nuclear medicine physician, ASO * The physician regularly interacts with people with advanced cancer * The physician is employed in an oncology hospital department Exclusion Criteria (physician): * The physician works mostly (\>50% of the time) in a hospital not involved in this study Inclusion Criteria (healthcare provider - potential implementer): * Healthcare provider (e.g., study coordinator, oncology coach) or another hospital staff member (e.g., administrative staff) * The implementer regularly interacts with people with advanced cancer Exclusion criteria (healthcare provider - potential implementer): \- Physician participating in My Care, My Voice Inclusion Criteria (patient): * The participant is an adult (18 years or older) * The participant has been diagnosed with advanced (i.e., non-curable) cancer (no curative treatment ongoing or planned). Participants receiving life-prolonging treatment are included. * The participant is aware of their diagnosis and treatment options as determined by their physician * The participant has known their initial diagnosis for more than one month * The participant is able to participate in a Dutch-language study * The participant is competent and able to voluntarily consent to participate in this study * The participant is hospitalized or receiving outpatient care Exclusion Criteria (patient): * Estimated survival prognosis by the physician is longer than 5 years * The participant is in a follow-up trajectory or in remission according to the physician * The participant is already receiving specialized palliative care known to the treating physician
Where it's running
-
AZorg
Aalst, East-Flanders, Belgium Recruiting -
AZ Maria Middelares
Ghent, East-Flanders, Belgium Recruiting -
Ghent University Hospital
Ghent, East-Flanders, Belgium Recruiting -
AZ Groeninge
Kortrijk, West-Flanders, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NUT Project: Nutritional Support in Thoracic Cancer
We’ll see if providing tailored nutrition guidance and assessment helps people with advanced lung cancer during their treatment.
-
Muscle Deterioration in Hospitalized Cancer Patients
A study test to see how muscle loss progresses in adults with cancer who are in the hospital and to help identify who might need muscle-support therapies.
-
Metamizole (Optalgin) impact on anti‑Xa levels in cancer patients on apixaban or rivaroxaban
This study will test whether taking metamizole (Optalgin) changes anti‑Xa blood levels in adults with cancer who are taking apixaban or rivaroxaban.
-
Financial burden for radiotherapy patients in Italy
This project will use a short Italian questionnaire to see if people getting radiotherapy in Italy face financial problems before, during, and after treatment.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.